Hospital
Our Lady of the Lake Assumption Community Hospital
Our Lady of the Lake Assumption Community Hospital was paid $6.03M by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is 99283, emergency room visit (moderate) — 68% of everything it billed.
33Billing provider infoOUR LADY OF THE LAKE ASSUMPTION COMMUNITY HOSPITAL
NAPOLEONVILLE, LA 70390
NAPOLEONVILLE, LA 70390
33aNPI1609860360assigned 09/08/2005
33bProvider typeCritical Access Hospital
28Total paid$6.03M
24GClaims39,825
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Louisiana
Rank by total paid#10 of 40
Median peer was paid$3.19M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,733 | $543K | |
| 2019 | 3,599 | $605K | |
| 2020 | 2,093 | $425K | |
| 2021 | 5,830 | $1.06M | |
| 2022 | 10,000 | $1.35M | |
| 2023 | 10,077 | $1.25M | |
| 2024incomplete | 5,493 | $801K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 68% | 11,205 | 10,305 | $4.12M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 23% | 4,808 | 4,513 | $1.42M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 2,538 | 2,081 | $144K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | <1% | 127 | 105 | $59K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,450 | 2,021 | $57K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 473 | 433 | $30K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 376 | 309 | $25K |
| 71045 | Radiologic examination, chest; single view | <1% | 438 | 380 | $24K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 877 | 809 | $22K |
| 80053 | Comprehensive metabolic panel | <1% | 2,626 | 2,318 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,343 | 1,182 | $17K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 60 | 29 | $16K |
26 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 51 | $12K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 245 | $10K |
| 99285 | Emergency room visit (most serious) | <1% | 18 | $10K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 508 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,614 | $8K |
| 87070 | <1% | 937 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,825 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 48 | $3K |
| 84484 | <1% | 465 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 329 | $3K |
| 81025 | <1% | 190 | $1K | |
| 81001 | <1% | 760 | $1K | |
| 82553 | <1% | 192 | $1K | |
| 83880 | <1% | 44 | $983.25 | |
| 82550 | <1% | 237 | $904.70 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,634 | $866.89 |
| 83690 | <1% | 153 | $705.91 | |
| 80061 | Lipid panel | <1% | 25 | $361.70 |
| 82077 | <1% | 37 | $310.86 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 48 | $282.64 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 27 | $255.41 |
| 85027 | <1% | 46 | $181.16 | |
| 85379 | <1% | 16 | $132.34 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $72.63 |
| 83605 | <1% | 12 | $57.85 | |
| 81003 | <1% | 29 | $23.05 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCLOWERS, JENNIFER (REGIONAL CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Lafayette Surgery Center Limited Partnership | Lafayette, LA | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.